(Q44726414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Aukje K Mantel-Teeuwisse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Olaf H Klungel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

W M Monique Verschuren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Arijan J Porsius

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Anthonius de Boer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

63-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-200427010-00004

17 November 2019

exact match

0 references

cites work

High persistence of statin use in a Danish population: compliance study 1993-1998.

1 reference

12 December 2020

Impact of pharmacist interventions on hospital readmissions for heart failure

1 reference

12 December 2020

Replacing short-acting nifedipine with alternative medications at a large health maintenance organization

1 reference

12 December 2020

Use and monitoring of "statin" lipid-lowering drugs compared with guidelines

1 reference

12 December 2020

Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts

1 reference

12 December 2020

Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol".

1 reference

12 December 2020

Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database

1 reference

12 December 2020

Life-threatening interaction of mibefradil and beta-blockers with dihydropyridine calcium channel blockers

1 reference

12 December 2020

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

12 December 2020

Withdrawal of statins increases event rates in patients with acute coronary syndromes

1 reference

12 December 2020

Third generation oral contraceptives. 12% of women stopped taking their pill immediately they heart CSM's warning.

1 reference

12 December 2020

Pharmaceutical care of patients with congestive heart failure: interventions and outcomes.

1 reference

12 December 2020

Cerivastatin and the dissemination of adverse event information

1 reference

12 December 2020

High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic

1 reference

12 December 2020

Consequences of a change in reimbursement status on prescription patterns

1 reference

12 December 2020

Discontinuation rates for use of statins are high

1 reference

12 December 2020

Increased thrombotic vascular events after change of statin

1 reference

12 December 2020

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

12 December 2020

Validation of pharmacy records in drug exposure assessment

1 reference

12 December 2020

Withdrawal of statins in patients with acute coronary syndromes

1 reference

12 December 2020

Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

12 December 2020

10.2165/00002018-200427010-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720086%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 November 2019

1043087494

0 references

1 reference